77 related articles for article (PubMed ID: 2022993)
1. Radiation absorbed dose calculations for samarium-153-EDTMP localized in bone.
Heggie JC
J Nucl Med; 1991 May; 32(5):840-4. PubMed ID: 2022993
[TBL] [Abstract][Full Text] [Related]
2. Intraorgan biodistribution and dosimetry of 153Sm-ethylenediaminetetramethylene phosphonate in juvenile rabbit tibia: implications for targeted radiotherapy of osteosarcoma.
Essman SC; Lewis MR; Miller WH
J Nucl Med; 2005 Dec; 46(12):2076-82. PubMed ID: 16330573
[TBL] [Abstract][Full Text] [Related]
3. Estimated human absorbed dose of a new (153)Sm bone seeking agent based on biodistribution data in mice: Comparison with (153)Sm-EDTMP.
Yousefnia H; Zolghadri S
Phys Med; 2015 Nov; 31(7):714-9. PubMed ID: 26095757
[TBL] [Abstract][Full Text] [Related]
4. Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases.
Bayouth JE; Macey DJ; Kasi LP; Fossella FV
J Nucl Med; 1994 Jan; 35(1):63-9. PubMed ID: 7505819
[TBL] [Abstract][Full Text] [Related]
5. [Radiopharmacokinetic and gammagraphic studies for calculating personalized dosimetry].
Arteaga de Murphy C; Pedraza-López M; Ferro-Flores G; Montoya-Molina CE; Meléndez-Alafort L
Rev Invest Clin; 2001; 53(3):228-34. PubMed ID: 11496710
[TBL] [Abstract][Full Text] [Related]
6. Samarium-153-EDTMP biodistribution and dosimetry estimation.
Eary JF; Collins C; Stabin M; Vernon C; Petersdorf S; Baker M; Hartnett S; Ferency S; Addison SJ; Appelbaum F
J Nucl Med; 1993 Jul; 34(7):1031-6. PubMed ID: 7686217
[TBL] [Abstract][Full Text] [Related]
7. High-dose treatment with (186)Re-HEDP or (153)Sm-EDTMP combined with amifostine in a rabbit model.
Brenner W; Kampen WU; von Forstner C; Brümmer C; Zuhayra M; Muhle C; Czech N; Henze E
J Nucl Med; 2001 Oct; 42(10):1545-50. PubMed ID: 11585871
[TBL] [Abstract][Full Text] [Related]
8. Radiation dose calculations in persons receiving injection of samarium-153 EDTMP.
Logan KW; Volkert WA; Holmes RA
J Nucl Med; 1987 Apr; 28(4):505-9. PubMed ID: 3572536
[TBL] [Abstract][Full Text] [Related]
9. (170)Tm-EDTMP: a potential cost-effective alternative to (89)SrCl(2) for bone pain palliation.
Das T; Chakraborty S; Sarma HD; Tandon P; Banerjee S; Venkatesh M; Pillai MR
Nucl Med Biol; 2009 Jul; 36(5):561-8. PubMed ID: 19520297
[TBL] [Abstract][Full Text] [Related]
10. Assessment of absorbed dose for Zr-89, Sm-153 and Lu-177 medical radioisotopes: IDAC-Dose2.1 and OLINDA experience.
Mostafa MYA; Zakaly HMH; Tekin HO; Issa SAM; Erdemir RU; Zhukovsky M
Appl Radiat Isot; 2021 Oct; 176():109841. PubMed ID: 34214913
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic and genotoxic effect of the [166Dy]Dy/166Ho-EDTMP in vivo generator system in mice.
Pedraza-López M; Ferro-Flores G; Arteaga de Murphy C; Morales-Ramírez P; Piedras-Ross J; Murphy-Stack E; Hernández-Oviedo O
Nucl Med Biol; 2004 Nov; 31(8):1079-85. PubMed ID: 15607490
[TBL] [Abstract][Full Text] [Related]
12. Radiation dose distribution within the bone marrow of patients receiving holmium-166-labeled-phosphonate for marrow ablation.
Bayouth JE; Macey DJ; Boyer AL; Champlin RE
Med Phys; 1995 Jun; 22(6):743-53. PubMed ID: 7565363
[TBL] [Abstract][Full Text] [Related]
13. Uptake of ethylenediamine tetramethylene phosphonic acid in normal bone after multiple applications. A non-human primate study.
Dormehl IC; Louw WK; Schneeweiss FH; Milner R; Schmitt G; Carl U; Croft SA
Arzneimittelforschung; 1998 Apr; 48(4):408-14. PubMed ID: 9608885
[TBL] [Abstract][Full Text] [Related]
14. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG
J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825
[TBL] [Abstract][Full Text] [Related]
15. Samarium-153-EDTMP dosimetry.
Heggie JC
J Nucl Med; 1994 Jan; 35(1):191-2. PubMed ID: 8271053
[No Abstract] [Full Text] [Related]
16. Internal dosimetry studies of
Shirmardi SP; Saniei E; Das T; Noorvand M; Erfani M; Bagheri R
Appl Radiat Isot; 2020 Dec; 166():109396. PubMed ID: 32889376
[TBL] [Abstract][Full Text] [Related]
17. Samarium-153-EDTMP in bone metastases.
Ahonen A; Joensuu H; Hiltunen J; Hannelin M; Heikkilä J; Jakobsson M; Jurvelin J; Kairemo K; Kumpulainen E; Kulmala J
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):123-7. PubMed ID: 7543288
[TBL] [Abstract][Full Text] [Related]
18. Estimated human absorbed dose of ¹⁷⁷Lu-BPAMD based on mice data: Comparison with ¹⁷⁷Lu-EDTMP.
Yousefnia H; Zolghadri S; Shanehsazzadeh S
Appl Radiat Isot; 2015 Oct; 104():128-35. PubMed ID: 26163291
[TBL] [Abstract][Full Text] [Related]
19. Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial.
Collins C; Eary JF; Donaldson G; Vernon C; Bush NE; Petersdorf S; Livingston RB; Gordon EE; Chapman CR; Appelbaum FR
J Nucl Med; 1993 Nov; 34(11):1839-44. PubMed ID: 8229221
[TBL] [Abstract][Full Text] [Related]
20. S values for radionuclides localized within the skeleton.
Bouchet LG; Bolch WE; Howell RW; Rao DV
J Nucl Med; 2000 Jan; 41(1):189-212. PubMed ID: 10647623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
